Primary research

Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice

Peter H Silverstone¹ , Robert Williams² , Louis McMahon² , Rosanna Fleming³ and Siobhan Fogarty²

¹  Biovail Corporation, Mississauga, Ontario, Canada

²  Biovail Technologies, Ltd, Dublin, Ireland

³  Statistical Department, Biovail Technologies, Ltd, Bridgewater, New Jersey, USA

author email corresponding author email

Annals of General Psychiatry 2008, 7:27doi:10.1186/1744-859X-7-27

Published:	23 December 2008

Abstract

Background

It is not known if there is a relationship between input rate and incidence of bupropion-induced seizures. This is important, since different controlled release formulations of bupropion release the active drug at different rates.

Methods

We investigated the effect of varying the intraperitoneal infusion rates of bupropion HCl 120 mg/kg, a known convulsive dose₅₀ (CD₅₀), on the incidence and severity of bupropion-induced convulsions in the Swiss albino mice. A total of 69 mice, approximately 7 weeks of age, and weighing 21.0 to 29.1 g were randomly assigned to bupropion HCl 120 mg/kg treatment by intraperitoneal (IP) administration in 7 groups (9 to 10 animals per group). Bupropion HCl was infused through a surgically implanted IP dosing catheter with infusions in each group of 0 min, 15 min, 30 min, 60 min, 90 min, 120 min, and 240 min. The number, time of onset, duration and the intensity of the convulsions or absence of convulsions were recorded.

Results

The results showed that IP administration of bupropion HCl 120 mg/kg by bolus injection induced convulsions in 6 out of 10 mice (60% of convulsing mice) in group 1. Logistic regression analysis revealed that infusion time was significant (p = 0.0004; odds ratio = 0.974) and increasing the IP infusion time of bupropion HCl 120 mg/kg was associated with a 91% reduced odds of convulsions at infusion times of 15 to 90 min compared to bolus injection. Further increase in infusion time resulted in further reduction in the odds of convulsions to 99.8% reduction at 240 min.

Conclusion

In conclusion, the demonstration of an inverse relationship between infusion time of a fixed and convulsive dose of bupropion and the risk of convulsions in a prospective study is novel.